Literature DB >> 3510763

Pathophysiology of coronary occlusion in acute infarction.

A Maseri, S Chierchia, G Davies.   

Abstract

Coronary angiography has proved beyond doubt that complete coronary occlusion is the rule in the very early hours of infarction. The 60% to 80% rate of coronary recanalization after thrombolytic therapy has proved that thrombosis is a major component of the occlusion at the time when the procedure is performed a few hours after the onset of symptoms. However, the trigger for coronary thrombosis and the causes of failure of thrombolytic therapy are still a matter of speculation. The relatively rare occurrence of acute coronary occlusion in the life of an individual with even severe coronary disease can be explained on the basis of the necessity of either extremely powerful isolated stimuli, which only occurs rarely, or the casual simultaneous presence in one coronary arterial segment of multiple unfavorable events, such as plaque fissuring, enhanced reactivity of coronary smooth muscle to constrictor stimuli and displacement of the thrombotic-thrombolytic equilibrium toward thrombosis. Coronary artery constriction possibly caused by vasoconstrictor substances released by thrombus, represents the potential element of a vicious cycle causing persistent coronary occlusion and reocclusion when reflow occurs with thrombolysis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510763     DOI: 10.1161/01.cir.73.2.233

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

1.  Holmium Laser-Induced Coronary Thrombolysis.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

2.  Effects of indobufen on platelet thromboxane B2 production in patients with myocardial infarction.

Authors:  A G Rebuzzi; A Natale; C Bianchi; F Mariello; E Coppola; G Ciabattoni
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Degree of luminal narrowing and composition of thrombus in plaque erosion.

Authors:  Osamu Kurihara; Masamichi Takano; Tsunenari Soeda; Francesco Fracassi; Makoto Araki; Akihiro Nakajima; Iris McNulty; Hang Lee; Kyoichi Mizuno; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2021-01       Impact factor: 2.300

Review 4.  Cardiovascular magnetic resonance: applications in daily practice.

Authors:  Ronny S Jiji; Christopher M Kramer
Journal:  Cardiol Rev       Date:  2011 Sep-Oct       Impact factor: 2.644

Review 5.  Acute coronary events.

Authors:  Armin Arbab-Zadeh; Masataka Nakano; Renu Virmani; Valentin Fuster
Journal:  Circulation       Date:  2012-03-06       Impact factor: 29.690

Review 6.  Mechanisms of myocardial ischemia.

Authors:  A Maseri
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

7.  Composition of coronary thrombus in acute myocardial infarction.

Authors:  Johanne Silvain; Jean-Philippe Collet; Chandrasekaran Nagaswami; Farzin Beygui; Kathryn E Edmondson; Anne Bellemain-Appaix; Guillaume Cayla; Ana Pena; Delphine Brugier; Olivier Barthelemy; Gilles Montalescot; John W Weisel
Journal:  J Am Coll Cardiol       Date:  2011-03-22       Impact factor: 24.094

Review 8.  The pathophysiology and epidemiology of myocardial infarction. A review.

Authors:  J Gill
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 9.  Management of vasospastic angina--role of nicorandil.

Authors:  J C Kaski
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

Review 10.  Aspirin in cardiovascular disease.

Authors:  I A Reilly; G A FitzGerald
Journal:  Drugs       Date:  1988-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.